分子生物学 Genetic and Environmental Determinants of Plasma Nitrogen Oxides and Risk of Ischemic Heart Disease Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy genetic basis for resistance to atherosclerosis Genetic Differences in Endothelial Cells May Determine Atherosclerosis Susceptibility Genetic Disorders of Cholesterol Biosynthesis in Mice and Humans Genetic Manipulation of Cardiac K+ Channel Function in Mice Genetic predisposition to coronary artery disease Genetic targeting for cardiovascular therapeutics Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial Infarction-A Systematic Review genetic-Advances in the genetics of cerebrovascular disease and stroke genetic-Advances in the molecular mechanisms of heart failure genetic-Angiotensinogen Gene Core Promoter Variants and Non-Modulating Hypertension genetic-Animal models of hypertrophic cardiomyopathy genetic-Apoptosis and cardiomyopathy genetic-Aspects of gene polymorphisms in cardiovascular disease-the renin-angiotensin system genetic-atrial form function_Lessons from Human Molecular Genetics genetic-Cardiomyopathy in animal models of muscular dystrophy genetic-Development of genetic hypotheses in essential hypertension genetic-DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress genetice-Molecular and Ionic Basis of Congenital Complete Heart Block genetice-Molecular Clock Mechanisms and Circadian Rhythms Intrinsic to the Heart genetice-Molecular Structure and Functional Role of Vascular Tight Junctions genetic-Endothelial Nitric Oxide Synthase Gene Sequence Variations and Vascular Disease genetices-Advances in cardiovascular genetics and embryology-role of transcription factors in congenital heart disease genetices-Atrial Form and Function-Lessons from Human Molecular Genetics genetices-Molecular and Ionic Basis of Congenital Complete Heart Block genetices-Molecular Structure and Functional Role of Vascular Tight Junctions genetices-New Aspect of the Research on Limb-Girdle Muscular Dystrophy 2A_A Molecular Biologic and Biochemical Approach to Pathology genetices-Nuclear factor kappa-B and the heart genetices-Phenotype-Driven Genetic Approaches in Mice; High-Throughput Phenotyping for Discovering New Models of Cardiovascular Disease genetices-Phenotype-Driven Genetic Approaches in Mice_High-Throughput Phenotyping for Discovering New Models of Cardiovascular Disease genetices-Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction genetices-The future of genetic association studies in hypertension_improving the signal-to-noise ratio genetices-The Heart SNPs a Beat; Polymorphisms in Candidate Genes for Cardiovascular Disease genetices-The Heart SNPs a Beat_Polymorphisms in Candidate Genes for Cardiovascular Disease genetic-Expression profiling of cardiac genes in human hypertrophic cardiomyopathy genetic-Familial dilated cardiomyopathy-from clinical presentation to molecular genetics genetic-Gene Mutation in Cardiac Myosin Binding Protein C genetic-Genetic Risk Factors for Venous Thrombosis genetic-Good medicines for bad genes genetic-Lipoprotein(a), Atherosclerosis, and Apolipoprotein(a) Gene Polymorphism genetic-Models of dilated cardiomyopathy in the mouse and the hamster genetic-Molecular aspects of arrhythmias associated with cardiomyopathies genetic-Molecular biology of arrhythmic syndromes genetic-On genetic and phenotypic variability of hypertrophic cardiomyopathy Genetics and dilated cardiomyopathy-limitations of candidate gene strategies Genetics and sudden cardiac death Genetics-concerning research in genetic markers of disease Genetics-Ethical and legal issues in genetic testing to Genetics-Genetic approaches for the investigation of genes associated with coronary heart disease Genetics-Genetics of coronary heart disease-Current knowledge and research principles genetics-Microarrays in Determining Molecular Phenotype in Cardiac Growth, Development, and Response to Injury Genetics of Cardiovascular Disease Genetics of Coronary Heart Disease_CURRENT UNDERSTANDING AND FUTURE PROSPECTS Genetics of inflammation and risk of coronary artery disease-the central role of interleukin-6 genetics-A Promising Genetic Approach to the Treatment of b-Thalassemia genetics-Advances in molecular genetics and pathology of cerebrovascular disorders genetics-Functional Genomics and Cardiovascular Drug Discovery genetics-Genetic determinants of coronary vasomotor tone in humans genetics-Is there a genetic basis for resistance to atherosclerosis genetics-Microarray-Gene Expression in Failing Hearts Surveyed by High-Density Microarrays genetics-MOLECULAR BASES OF CIRCADIAN RHYTHMS genetics-Molecular genetic basis of sudden cardiac death genetics-Molecular genetics of G proteins and atherosclerosis risk genetics-Molecular Pathogenesis of the Antiphospholipid Syndrome genetics-Molecular regulation of lymphangiogenesis and targets for tissue oedema genetics-Myogenic satellite cells-physiology to molecular biology genetics-NHLBI Genomics Initiatives genetics-Nongenomic regulation of ENaC by aldosterone genetics-Real-time RT-PCR for the Detection of Beta-adrenoceptor Messenger RNAs genetics-Sterol Regulatory Element-binding Protein-1 as a Dominant Transcription Factor for Gene Regulation of Lipogenic Enzymes in the Liver genetics-The LDL Receptor Gene Family-(Un)Expected Signal Transducers in the Brain genetics-Troponin I Isoforms and Chimeras-Tuning the Molecular Switch of Cardiac Contraction genetics-Tumors and the heart-molecular genetic advances genetic-The molecular pathogenesis of the Marfan syndrome genetictic-Genetic basis of syndromes associated with congenital heart disease genetictic-Mitochondria and the heart genetictic-Molecular genetics genetictic-Tumors and the heart-molecular genetic advances genome--Genetic analysis for common complex disease genome--Genetic susceptibility to cardiovascular diseases genome--Genetics, genomics, proteomics-What is a cardiologist to do genome-A Genomic-Systems Biology Map for Cardiovascular Function Genomic and Proteomic Databases_Large-Scale Analysis and Integration of Data proteome-Conserved Cardiogenic Functions of the Multitype Zinc-Finger Proteins proteome-Genetic Approach to Detect Muscle Protein Interactions in vivo Proteomic-Application of Proteomics to the Study of Cardiovascular Biology proteomics-Application of Proteomics to the Study of Cardiovascular Biology Proteomics-Cardiovascular Proteomics-Evolution and Potential 细胞生物学 cell-A Novel Role for STAT3 in Cardiac Remodeling cell-A Role for the Actin Cytoskeleton in the Initiation and Maintenance of Store-Mediated Calcium Entry in Human Platelets cell-Activation of the Small GTP-binding Protein Ras in the Heart by Hypertrophic Agonists cell-Adhesion receptors of vascular smooth muscle cells and their functions cell-Allocation and Early Differentiation of Cardiovascular Progenitors in the Mouse Embryo cell-Angiomotin Regulates Endothelial Cell Motility cell-Angiotensin II Induces Phenotype-Dependent Apoptosis in Vascular Smooth Muscle Cells cell-Apoptosis in the Heart-About Programmed Cell Death and Survival cell-Apoptosis of Smooth Muscle Cells Is Not Silent; Fas-FADD Initiates a Program of Inflammatory Gene Expression cell-Apoptosis of Smooth Muscle Cells Is Not Silent_Fas-FADD Initiates a Program of Inflammatory Gene Expression cell-Calcium Signal Transmission between Ryanodine Receptors and Mitochondria in Cardiac Muscle cell-Cardiac Myocyte Adenosine Receptors and Caveolae cell-Cardiac Na+-Ca2+ Exchange-Molecular and Pharmacological Aspects cell-cardioprotection-Modulation of sarcoplasmic reticulum function-A new strategy in cardioprotection cell-channe-an endothelial Ca2+ entry channel with dual mechanosensitivity cell-channel-Aquaporins-Phylogeny, Structure, and Physiology of Water Channels cell-channel-Ca2+-Activated Cl– Channels cell-channel-Cardiac channelopathies cell-channel-CFTR Chloride Channels-Binding Partners and Regulatory Networks cell-channel-Developmental Clustering of Ion Channels cell-channel-ERG Proteins and Functional Cardiac IKr Channels in Rat, Mouse, and Human Heart cell-channel-High-Throughput Screening Strategies for Cardiac Ion Channels cell-channel-Inherited Sodium Channelopathies; Novel Therapeutic and Proarrhythmic Molecular Mechanisms cell-channel-Ion Channels and Their Functional Role in Vascular Endothelium cell-channel-KCNQ potassium channels-physiology, pathophysiology, and pharmacology cell-channel-Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system cell-channel-physiol-Extracellular Surface Charges in Voltage-Gated Ion Channels cell-channel-PI3King the L-Type Calcium Channel Activation Mechanism cell-channel-Postulated Role of Inter-domain Interaction within the Ryanodine Receptor in Ca2+ Channel Regulation cell-channel-Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a,b) by protein kinases cell-channel-Regulation of the Cardiac Repolarizing HERG Potassium Channel by Protein Kinase A cell-Channels-High-Throughput Screening Strategies for Cardiac Ion Channels cell-channels-How Calcium Influx through Calcium Leak Channels Is Responsible for the Elevated Levels of Calcium-dependent Proteolysis in Dystrophic Myotubes cell-channel-Surface Expression of Kv1 Voltage-Gated K+ Channels Is Governed by a C-terminal Motif cell-chennal-Requirement of a Macromolecular Signaling Complex for Adrenergic Receptor Modulation of the KCNQ1-KCNE1 Potassium Channel cell-Current Perspective on the Role of Apoptosis in Atherothrombotic Disease cell-Cytochrome P450 2C is an EDHF Synthase in Coronary Arteries cell-Cytochrome P450 and Vascular Homeostasis cell-Decreased Expression of Insulin-like Growth Factor-1 and Apoptosis of Vascular Smooth Muscle Cells cell-Direct Vascular Effects of HMG-CoA Reductase Inhibitors cell-Distribution and role of Na+ase in endocardial endothelium cell-Endoglin-deficient Mice, a Unique Model to Study Hereditary Hemorrhagic Telangiectasia cell-Endoplasmic reticulum in the heart cell-Endothelial Cell Apoptosis-for Atherosclerosis cell-Endothelin-1 Synthesis and Receptor Expression in Human Coronary Artery Smooth Muscle Cells cell-Eph Receptors and Ephrin Ligands_Essential Mediators of Vascular Development cell-ErbB4 and Its Isoforms_Selective Regulation of Growth Factor cell-Exploring the Role of the-Adrenergic Receptor Kinase in Cardiac Disease Using Gene-Targeted Mice cell-Extracellular Matrix-Driven Matrix Metalloproteinase Production in Endothelial Cells Implications for Angiogenesis cell-Extracellular Matrix-Driven Matrix Metalloproteinase Production in Endothelial Cells; Implications for Angiogenesis cell-Functional Properties of Failing Human Ventricular Myocytes cell-Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart cell-Increased Rate of Apoptosis in Intimal Arterial Smooth Muscle Cells Through Endogenous Activation of TNF Receptors cell-Inhibition of Stress-Activated p38 Mitogen-Activated Protein Kinase Induces Low-Density Lipoprotein Receptor Expression cell-Integrating the VEGF Signals Leading to Actin-Based Motility in Vascular Endothelial Cells cell-Integrin and Growth Factor Receptor Crosstalk cell-Integrins and the Myocardium cell-Integrins in Vascular Development cell-Involvement of the cardiac ryanodine receptor-calcium release channel in catecholaminergic polymorphic ventricular tachycardia cell-Ligands for Peroxisome Proliferator-Activated Receptor Inhibit Monocyte CCR2 Expression Stimulated by Plasma Lipoproteins cell-Mitochondria and the heart cell-Mitochondria-Gateway for Cytoprotection cell-Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor cell-Mitochondrial Coupling Factor 6 Is Present on the Surface of Human Vascular Endothelial Cells cell-Molecular mechanisms of iNOS induction by IL-1 and IFN-in rat aortic smooth muscle cells cell-Myocardial Diseases cell-Peroxisome Proliferator–Activated Receptor-Ligands Inhibit Nuclear but Not Extracellular Signal-MAPK cell-Phospholipase A2 in Vascular Disease cell-Phospholipase C Isoforms, Cytoskeletal Organization, and Vascular Smooth Muscle Differentiation cell-PPAR agonists as direct modulators of the vessel wall in cardiovascular disease cell-PPAR Signaling in the Control of Cardiac Energy Metabolism cell-Regulation of MEF2 by p38 MAPK and Its Implication in Cardiomyocyte Biology cell-Regulation of the Cardiac Repolarizing HERG Potassium Channel by Protein Kinase A cell-Regulators of G-protein Signaling in Receptor Complexes cell-Salicylates and Vascular Smooth Muscle Cell Proliferation-Molecular Mechanisms for Cell Cycle Arrest cell-Salicylates and Vascular Smooth Muscle Cell Proliferation; Molecular Mechanisms for Cell Cycle Arrest cell-Sequence Determinants of Function and Evolution in Serine Proteases cell-Seven-transmembrane-spanning receptors and heart function cell-SH3 domains-complexity in moderation cell-Signaling of G12 Family of G Proteins Through a Tyrosine Kinase and a Ras-GAP cell-The Gas6-Axl System; A Novel Regulator of Vascular Cell Function cell-The Gas6-Axl System_A Novel Regulator of Vascular Cell Funct cell-Thrombin Stimulation of the Vascular Cell Adhesion Molecule-1 Promoter in Endothelial Cells Is Mediated by Tandem Nuclear Factor-B and GATA Motifs cell-Tissue Factor-dependent Factor VIIa Signaling cell-Upstream Stimulatory Factors Regulate Aortic Preferentially Expressed Gene-1 Expression in Vascular Smooth Muscle Cells cell-Vascular Smooth Muscle Growth-Autocrine Growth Mechanisms cell-Vascular endothelial cells express isoforms of protein kinase A inhibitor 生理病理学 pathol-Heme Oxygenase-1 in Tissue Pathology-The Yin and Yang pathol-Ischemic preconditioning; From basic mechanisms to clinical applications pathol-Vascular pathology-a pathogenetic challenge for a new millennium pathol-Vascular-Atherosclerosis, inflammation, and infection pathol-vascular-Cardiac Myosin and the TH1-TH2 Paradigm in Autoimmune Myocarditis pathol-vascular-Glomeruloid Microvascular Proliferation Orchestrated by VPF-VEGF-A New World of Angiogenesis Research pathol-vascular-Hypertrophic cardiomyopathy pathol-Vascular-Improving vascular grafts-the importance of mechanical and haemodynamic properties pathol-Vascular-Interactions between cancer cells and the endothelium in metastasis pathol-Vascular-Malignant hypertension-the role of the paracrine renin-angiotensin system pathol-Vascular-Microcirculatory dysfunction in sepsis-a pathogenetic basis for therapy pathol-Vascular-Molecular mechanisms in intimal hyperplasia pathol-Vascular-Molecular mechanisms that control endothelial cell contacts pathol-Vascular-Nitric oxide in the pathogenesis of vascular disease pathol-Vascular-Pathogenesis of ANCA-associated systemic vasculitis pathol-Vascular-Pathophysiology of ischaemia-reperfusion injury pathol-Vascular-Regulation of inflammatory vascular damage pathol-Vascular-The clinical manipulation of angiogenesis-pathology, side-effects, surprises, and opportunities with novel human therapies pathol-Vascular-The pathophysiology of the collateral circulation (arteriogenesis) pathol-Vascular-The role of apoptosis in vascular disease pathol-vascular-Transgenic mouse models in angiogenesis and cardiovascular disease pathol-Vascular-Vascular protease receptors-integrating haemostasis and endothelial cell functions pathol-Vasculogenic Mimicry-How Convincing, How Novel, and How Significant physiol-A Novel Role for Serotonin in Heart physiol-Age-dependent variation in contractility of adult cardiacmyocytes Physiol-Adenosine 5'-Triphosphate-a P2-Purinergic Agonist in the Myocardium physiol-Adenosine A1 and A3 receptors-Distinct cardioprotection physiol-Adenosine receptor signaling in vitro and in vivo physiol-adenosine-The role of adenosine in preconditioning physiol-adenosine-Functional and molecular evidence of adenosine A2A receptor in coronary arteriolar dilation to adenosine physiol-adenosine-New insights into adenosine receptor modulation of myocardial ischemia-reperfusion injury physiol-adenosine-Vascular effects of adenosine and its analogues physiol-Adhesion events in angiogenesis physiol-Advances in Parasympathetic Control of Heart Rate and Cardiac Function physiol-Aldosterone and the Heart physiol-An Autocrine-Paracrine Mechanism Triggered by Myocardial Stretch Induces Changes in Contractility physiol-Anti-Inflammatory Mechanisms in the Vascular Wall physiol-Antioxidants-an integrative approach physiol-Biochemistry, physiology and pathophysiology of the extracellular calcium-sensing receptor physiol-Ca2+ Sparks in Cardiac Muscle physiol-Calcium and Cardiac Rhythms-Physiological and Pathophysiological physiol-Calmodulin and Excitation-Contraction Coupling physiol-Cardiac excitation–contraction coupling physiol-Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart physiol-cardioprotection-Opioids and cardioprotection physiol-cardioprotective-novel insight into the cardioprotective effects of prostaglandins physiol-Cardiovascular effects of erythropoietin and anemia correction physiol-Cardiovascular endocrinology-into the new millennium physiol-Central Neuronal Histamine Contributes to Cardiovascular Regulation physiol-Chronic and acute effects of oestrogens on vascular contractility physiol-Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues physiol-Coronary microcirculation; Physiology and pharmacology physiol-coronary no-reflow phenomenon-a review of mechanisms and therapies physiol-Current Status of Acrolein as a Lipid Peroxidation Product physiol-Cytoskeletal regulation of pulmonary vascular permeability physiol-Cytosolic Calcium Oscillations in Smooth Muscle Cells physiol-Developmental aspects of oxygen sensing by the carotid body physiol-Electrophysiology of the Sodium-Potassium-ATPase in Cardiac cell physiol-Emerging Role of the JAK-STAT Pathway as a Mechanism of Protection Against Ischemia physiol-Endothelium-Derived Hyperpolarizing Factor physiol-Flow-mediated dilatation in human circulation-diagnostic and therapeutic aspects physiol-Free Radicals in the Physiological Control of Cell Function physiol-Functional Correlates of Central Arterial Geometric Phenotypes physiol-Haeme oxygenase-1 and cardiac anaphylaxis physiol-Heat Shock Proteins and Cardiovascular Pathophysiology physiol-Heat Shock Proteins and Cardiovascular Pathophysiology-1 physiol-Heat Shock Proteins and Cardiovascular Pathophysiology-2 physiol-Heterogeneous control of blood flow amongst different vascular beds physiol-HIF-1-mediator of physiological and pathophysiological responses to hypoxia physiol-Human macrophage adhesion on fibronectin physiol-Hypoxia-Inducible Factor 1-Control of Oxygen Homeostasis in Health and Disease physiol-images of Action Potential Propagation in Heart physiol-Information Networks in the Arterial Wall physiol-Invasive Cardiac Electrophysiology in the Mouse; Techniques and Applications physiol-Invasive Cardiac Electrophysiology in the Mouse_Techniques and Applications physiol-Ion Channels and Their Functional Role in Vascular Endothelium cell physiol-IP-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function physiol-Isoform-Specific Regulation of the Na+-K+ Pump in Heart physiol-Mechanics of Relaxation of the Human Heart physiol-Mechanism of Cardiac Fibrosis by Angiotensin physiol-Method for non-invasively recording electrocardiograms in conscious mice physiol-Mitochondria-a target for myocardial protection physiol-Multiple role of reactive oxygen species in the arterial wall physiol-Myocardial Reperfusion Injury-Insights Gained from Gene-Targeted Mice physiol-Myocyte renewal and ventricular remodelling physiol-Myoglobin-Just an Oxygen Store or Also an Oxygen Transporter physiol-Negative Fluid Balance Predicts Survival in Patients With Septic Shock physiol-Neural influences on cardiovascular variability-possibilities and pitfalls physiol-Nitric oxide and cytochrome oxidase-substrate, inhibitor or effector physiol-Nitric oxide-hormones, metabolism, and function physiol-No Role for the Ryanodine Receptor in Regulating Cardiac Contraction physiol-NO-Bioenergetics in cardiac hypertrophy-mitochondrial respiration as a pathological target of NO physiol-NO-Mechanisms whereby rapid RV pacing causes LV dysfunction-perfusion-contraction matching and NO physiol-NO-Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway physiol-Noninvasive tests of vascular function and structure physiol-Noninvasive tests of vascular function and structure physiol-Nontraditional aspects of aldosterone physiology physiol-NO-Reversible inhibition of cellular respiration by nitric oxide in vascular inflammation physiol-Office Blood Pressures, Arterial Compliance Characteristics, and Estimated Cardiac Load Physiological and Genomic Consequences of Intermittent Hypoxia-Chemoreflex responses to CO2 Physiological and Genomic Consequences of Intermittent Hypoxia Physiological and Genomic Consequences of Intermittent Hypoxia-Adaptive responses of skeletal muscle to intermittent hypoxia Physiological and Genomic Consequences of Intermittent Hypoxia-Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats Physiological and Genomic Consequences of Intermittent Hypoxia-Improved anoxic tolerance in rat diaphragm following intermittent hypoxia Physiological and Genomic Consequences of Intermittent Hypoxia-Intermittent hypoxia and respiratory plasticity Physiological and Genomic Consequences of Intermittent Hypoxia-Osteocytes upregulate HIF-1 in response to acute disuse and oxygen deprivation Physiological and Genomic Consequences of Intermittent Hypoxia-Oxygen sensing during intermittent hypoxia-cellular and molecular mechanisms Physiological and Genomic Consequences of Intermittent Hypoxia-Phrenic long-term facilitation requires 5-HT receptor activation Physiological and Genomic Consequences of Intermittent Hypoxia-Physiological consequences of intermittent hypoxia-systemic blood pressure Physiological and Genomic Consequences of Intermittent Hypoxia-Pulmonary hypertension in mice following intermittent hypoxia Physiological and Genomic Consequences of Intermittent Hypoxia-Regulation of sleep-in response to intermittent hypoxic stimuli applied only in sleep Physiological and Genomic Consequences of Intermittent Hypoxia-Respiratory plasticity following intermittent hypoxia Physiological and Genomic Consequences of Intermittent Hypoxia-Role of spleen emptying in prolonging apneas in humans Physiological and Genomic Consequences of Intermittent Hypoxia-Variation in acute hypoxic ventilatory response is linked to mouse chromosome 9 Physiological and pathophysiological role of magnesium in the cardiovascular system_implications in hypertension Physiological andGenomic Consequences of Intermittent Hypoxia-Physiological and pathophysiological responses to intermittent hypoxia Physiology-Nitric oxide and respiration physiol-Origin on the electrocardiogram of U-waves and abnormal U-wave inversion physiol-Oxygen Radicals as Messengers in Oxygen-Dependent Gene Expression physiol-Oxygen sensing by the carotid body chemoreceptors physiol-Paracrine and autocrine effects of nitric oxide on myocardial function physiol-Pathophysiological effects of aldosterone in cardiovascular tissues physiol-Pericardial fluid as a new material for clinical heart research physiol-Physiological limitations on the regulation of smooth muscle contraction physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle physiol-Plasticity in Skeletal, Cardiac, and Smooth muscle-Contractile activity-induced mitochondrial biogenesis in skeletal muscle physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle-Effect of the aldehyde acrolein on acetylcholine-induced membrane current in airway smooth muscle cells physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle-Effects of contractile activity on mitochondrial transcription factor A expression in skeletal muscle physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle-Historical Perspectives-Plasticity of mammalian skeletal muscle physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle-IGF-I antibody prevents increases in protein synthesis in epitrochlearis muscles physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle-Low-frequency stimulation of fast muscle affects the abundance of Ca2+-ATPase physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle-Molecular mechanisms of phenotypic plasticity in smooth muscle cells physiol-Plasticity in Skeletal, Cardiac, and Smooth Muscle-Plasticity of airway smooth muscle stiffness and extensibility physiol-Plasticity in Skeletal, Cardiac,and Smooth Muscle-Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation physiol-Plasticity in Skeletal,Cardiac, and Smooth Muscle-Mechanisms underlying increased force generation by rat diaphragm muscle fibers during development physiol-Plasticity in Sphysiol-keletal, Cardiac, and Smooth Muscle-Skeletal muscle focal adhesion kinase, paxillin, and serum response factor are loading dependent physiol-Plasticity inphysiol-Skeletal, Cardiac, and Smooth Muscle physiol-Plasticity inphysiol-Skeletal, Cardiac, and Smooth Muscle-Effect of chronic passive length change on airway smooth muscle length-tension relationship physiol-Precondition-Essential Role of Oxygen Radicals in Delayed Pharmacological Preconditioning physiol-Preconditioning-Role of STAT3 in Ischemic Preconditioning physiol-Precondition-Metabolism of Preconditioned Myocardium physiol-Prostaglandin H Synthase and Vascular Function physiol-Protecting the Myocardium From Ischemic Injury-A Critical Role for 1-Adrenoreceptors physiol-Protein kinase C activation and cardioprotective effect of preconditioning with oxidative stress in isolated rat heart physiol-Regulation of coronary vasomotor tone under normal conditions and during acute myocardial hypoperfusion physiol-Regulation of Matrix Proteins and Impact on Vascular Structure physiol-Regulation of oxygen sensing in peripheral arterial chemoreceptors physiol-Remodeling-Gq-Coupled Receptor Signaling in Pathological Ventricular Remodeling physiol-Reperfusion Injury Revisited; Is There a Role for Growth Factor Signaling in Limiting Lethal Reperfusion Injury physiol-Role of calcium as activator of cardiac contraction physiol-Role of calcium as activator of cardiac contraction-2 physiol-Role of Nitric Oxide in Buffering Short-Term Blood Pressure Fluctuations physiol-Role of phosphate and calcium stores in muscle fatigue physiol-role of the family of 17beta-hydroxysteroid dehydrogenases in human physiology and disease physiol-Sex and the heart-what is the role of the cardiologist physiol-Sexual activity- physiol-Sexual activity-Androgens and coronary artery disease. A sex-specific effect of sex hormones physiol-Sexual activity-Cardiac disease, anxiety, and sexual functioning physiol-Sexual activity-Cardiovascular response to sexual activity physiol-Sexual activity-Cardiovascular risk and sildenafil physiol-Sexual activity-Central control of the cardiovascular and erection systems physiol-Sexual activity-Evaluating the cardiovascular tolerance for sex physiol-Sexual activity-Introductory comments physiol-Sexual activity-Management of sexual dysfunction in patients with cardiovascular disease physiol-Sexual activity-mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction physiol-Sexual activity-Penile erection and cardiac risk physiol-Sexual activity-Sex and myocardial infarction physiol-Sexual activity-Sexual activity and cardiac risk physiol-Sexual activity-Sexual activity and cardiac risk-is depression a contributing factor physiol-Sexual activity-Sexual intercourse and stable angina pectoris physiol-Sexual activity-Sympathetic nervous system activity and female sexual arousal physiol-Sexual activity-Triggering of cardiac events by sexual activity physiol-Signal ransduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells physiol-Signal transduction of ischemic preconditioning physiol-Skeletal and Cardiac Muscle Contractile Activation-Tropomyosin Rocks and Rolls physiol-Sodium-Calcium Exchange-Its Physiological Implications physiol-SPARC and the Kidney Glomerulus_Matricellular Proteins Exhibit Diverse Functions under Normal and Pathological Conditions physiol-Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology physiol-Stress Protein Involvement in Cardioprotection Induced by Hypothermia physiol-Stress Testing in Cardiac Evaluation-Current Concepts With Emphasis on the ECG physiol-Structure of Calcium-Free Human m-Calpain; Implications for Calcium Activation and Function physiol-Subcellular Ca2+ Dynamics physiol-Sympathetic modulation of blood pressure variability physiol-The Biology of Myocardial Hibernation physiol-the heart physiol-The Hypothalamus and Hypertension physiol-The Last Frontier in Cardiovascular Health physiol-The late open artery hypothesis-A decade later physiol-The pathophysiology of cardiac syndrome X physiol-Time versus frequency domain techniques for assessing baroreflex sensitivity physiol-Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation physiol-Troponin I Isoforms and Chimeras-Tuning the Molecular Switch of Cardiac Contraction physiol-Updated pathophysiologic concepts in unstable coronary artery disease physiol-Urocortin-A Novel Player in Cardiac Control physiol-Vascular adaptation to microgravity-what have we learned physiol-Vascular endothelial dysfunction-does tetrahydrobiopterin play a role physiol-Vascular Endothelium-Checkpoint for Inflammation and Immunity physiol-Vascular Smooth Muscle Growth-Autocrine Growth Mechanism physiol-Vascular Smooth Muscle Growth-Autocrine Growth Mechanisms physiol-Vascular Structure Determines Pulmonary Blood Flow Distribution physiol-Wave-intensity analysis-a new approach to coronary hemodynamics physiol-What Does the Brain Know About Blood Pressure physiol-What Does the Brain Know About Blood Pressure physiol-NO-Nitric oxide and cGMP protein kinase activity in aged ventricular myocytes physiol-Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors physiol-The athlete's heart 药理治疗学 drug-reversibility of competitive glycoprotein IIb-IIIa receptor-directed platelet inhibition Drug therapy or coronary angioplasty for the treatment of coronary artery disease-New insights drug-Advanced coronary artery disease-Appropriate end points for trials of novel therapies drug-Assessment of low-molecular-weight heparin trials in cardiology drug-Cholesterol lowering in the older population drug-Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis drug-Heart and Drug Therapy drug-Lipid lowering medication and hepatotoxicity drug-New antiarrhythmic agents-a conceptually novel approach drug-New antiarrhythmic agents drug-New Antiarrhythmic Drugs for Atrial Flutter and Atrial Fibrillation drug-New Approaches to Antiarrhythmic Therapy, Part I-Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias drug-New Approaches to Antiarrhythmic Therapy, Part II-Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias drug-New approaches to antiarrhythmic therapy drug-New targets for antithrombotics and anticoagulants- drug-New targets for antithrombotics and anticoagulants-Conclusion drug-New targets for antithrombotics and anticoagulants-New anticoagulants drug-New targets for antithrombotics and anticoagulants-New data in treatment of acute coronary syndromes drug-New targets for antithrombotics and anticoagulants-Pentasaccharide Org31540-SR90107A clinical trials update drug-New targets for antithrombotics and anticoagulants-Recent advances in anticoagulant therapy for acute coronary syndromes drug-New Technologies and Infection Control Practices to Prevent Intravascular Catheter-related Infections drug-Orbofiban-An orally active GPIIb-IIIa platelet receptor antagonist drug-Orbofiban-An orally active GPIIb-IIIa platelet receptor antagonist drug-perindopril-Dosage considerations with perindopril for systemic hypertension drug-perindopril-Effects of perindopril on cardiovascular remodeling drug-perindopril-Efficacy of perindopril in the treatment of systemic drug-perindopril-Introduction drug-perindopril-Safety profile of perindopril drug-Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors drug-SCAP ligands are potent new lipid-lowering drugs drug-Searching for Alternatives to Heparin_Sulfated Fucans from Marine Invertebrates drug-Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL drug-statins-2-Economics of lipid lowering in primary prevention drug-statins-2-high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management drug-statins-2-Introduction-2 drug-statins-2-low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management drug-statins-2-Novel approaches to lipid lowering-what is on the horizon drug-statins-2-Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor drug-statins-2-Statin therapy and reductions in low-density lipoprotein cholesterol drug-statins-2-Statin therapy drug-statins-Are we aggressive enough in lowering cholesterol drug-statins-Developing a clinical strategy for cholesterol management in an era of unanswered questions drug-statins-Effectiveness of statins in acute coronary syndromes drug-statins-Emerging mechanisms for secondary cardioprotective effects of statins drug-statins-Going from immutable to mutable atherosclerotic plaques drug-statins-Introduction drug-statins-Making practical sense of clinical trial data in decreasing cardiovascular risk drug-statins-Ongoing clinical trials of statins drug-statins-Pleiotropic effects of statins and their clinical significance drug-statins-secondary cardioprotective effects of statins drug-statins-What are the priorities for managing cholesterol effectively drug-Testosterone-a natural tonic for the failing heart drug-Cilostazol-Treatment of Intermittent Claudication drug-Fibrinolytic Therapy in Intraventricular Hemorrhage drug-L-Arginine in the Management of Cardiovascular Diseases drug-Micronized Fenofibrate-A New Fibric Acid Hypolipidemic Agent drug-Risks and Benefits of Glycoprotein IIb-IIIa Antagonists in Acute Coronary Syndrome drug-Role of Anagrelide in the Treatment of Thrombocytosis drug-Tenecteplase for Treatment of Acute Myocardial Infarction pharmacol-Mutations of Protease-Activated Receptor-1 Result in Differential Activation by Thrombin and Thrombin Receptor Agonist Peptide pharmacol--rostaglandin H Synthase and Vascular Function pharmacol-Identification and functional characterization of α2-adrenoceptor polymorphisms pharmacol-Molecular genetics of Ca2+ stores and intracellular Ca2+ signalling pharmacol-Molecular pathophysiology and targeted therapeutics for muscular dystrophy pharmacol-Protein kinases: tuners of the BKca channel in smooth muscle pharmacol-Use of transgenic mice to study voltage-dependent Ca2+ channels pharmacol-1-Adrenergic receptor regulation-basic science and clinical implications pharmacol-1-Adrenergic Receptors-New Insights and Directions pharmacol-2-Adrenoceptors and ventricular fibrillation pharmacol-A3 Adenosine Receptor Ligands-History and Perspectives pharmacol-Adenine Nucleotide Translocator in Heart pharmacol-Adenosine A2A and A2B receptors mediated nitric oxide production in coronary artery endothelial cells pharmacol-Adenosine-Nomenclature and Classification of Adenosine Receptors pharmacol-Adenosine Receptor Ligands-History and Perspectives pharmacol-Adenosine, adenosine receptors and myocardial protection pharmacol-Adrenergic and Muscarinic Receptors in the Human Heart pharmacol-Adrenergic axis and heart disease pharmacol-Adrenergic Receptors-New Insights and Directions pharmacol-Adrenergic Receptors, Transgenic Mice, and Pharmacological Model Systems pharmacol-Adrenergic regulation of cardiac myocyte apoptosis pharmacol-adrenoceptor subtypes pharmacol-Antioxidant Therapy-A New Pharmacological Approach in Shock, Inflammation, and Ischemia-Reperfusion Injury pharmAcol-Apoptosis in atherosclerosis-pathological and pharmacological implications pharmacol-Bucillamine Prevents Myocardial Reperfusion Injury PHARMACOL-Ca2+-CaM-DEPENDENT KINASES-From Activation to Function pharmacol-Cerebrovascular structure and dementia-new drug targets PHARMACOL-COMPARTMENTATION OF G PROTEIN-COUPLED SIGNALING PATHWAYS IN CARDIAC MYOCYTES pharmacol-Direct effects of estrogen on the vessel wall pharmacol-Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors pharmacol-Dopamine receptor functions pharmacol-Dopamine Receptors-From Structure to Function pharmacol-Effects of Nebivolol on Human Platelet Aggregation pharmacol-Endocannabinoids and Vascular Function pharmacol-Endothelial Adrenoceptors pharmacol-Guanylyl Cyclases and Signaling by Cyclic GMP pharmacol-In Vivo Gene Modification Elucidates Subtype-Specific Functions of 2-Adrenergic Receptors pharmacol-Insulin Inhibits Coronary Endothelial Cell Calcium Entry and Coronary Artery Relaxation pharmacol-Limited Effect of Systemic beta-Blockade on Sympathetic Outflow PHARMACOL-LYSOPHOSPHOLIPID RECEPTORS pharmAcol-Modulation of transmitter release via presynaptic cannabinoid receptors PHARMACOL-MOLECULAR APPROACH TO ADENOSINE RECEPTORS-Receptor-Mediated Mechanisms of Tissue Protection pharmAcol-Muscarinic receptors in the Mammalian Heart pharmacol-Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature pharmacol-New Molecular Targets for Cholesterol-Lowering Therapy pharmacol-Norepinephrine and 2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function PHARMACOL-NOVEL EFFECTS OF NITRIC OXIDE Pharmacological modulation, preclinical studies, and new clinical features of myocardial ischemic preconditioning Pharmacology of Capacitative Calcium Entry pharmacol-Oxidative pathways in cardiovascular disease-roles, mechanisms, and therapeutic implications pharmacol-Oxidative stress and vascular smooth muscle cell function in liver disease pharmacol-Pharmacologic therapy of persistent pulmonary hypertension of the newborn PHARMACOL-PHYSIOLOGICAL FUNCTIONS OF CYCLIC ADP-RIBOSE AND NAADP AS CALCIUM MESSENGERS pharmacol-Post-Translational Control of Endothelial Nitric Oxide Synthase PHARMACOL-PROSTANOID RECEPTORS-Subtypes and Signaling pharmacol-Receptor Binding and Agonist Efficacy-New Insights from Mutants of the Thrombin Protease-Activated Receptor-1 PHARMACOL-REGULATION AND ROLE OF ADENYLYL CYCLASE ISOFORMS pharmacol-Regulation of-Adrenoceptor Signaling in Cardiac Function and Disease pharmAcol-Regulation of Ins(1,4,5)P3 receptor isoforms by endogenous modulators pharmacol-Regulator of G Protein Signaling Proteins-Novel Multifunctional Drug Targets pharmacol-Selective Ligands for Lysophosphatidic Acid Receptor Subtypes pharmacol-Splice Variants of GPCRs pharmacol-Structural Mimicry in G Protein-Coupled Receptors PHARMACOL-THE CLINICAL PHARMACOLOGY OF L-ARGININE pharmacol-Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine pharmacol-Transgenic Studies of Cardiac Adrenergic Receptor Regulation pharmacol-Transgenic Studies of Cardiac Adrenergic Receptor Regulation PHARMACOL-PROSTANOID RECEPTORS-Subtypes and Signaling therapy for acute myocardial infarction-Achieving tissue-level perfusion in the setting of acute myocardial infarction therapy for acute myocardial infarction-benefits of bolus thrombolytic agents therapy for acute myocardial infarction-IIb's are not IIb's therapy for acute myocardial infarction-Introduction therapy for acute myocardial infarction-low-molecular-weight heparins in the management of patients with unstable angina pectoris and non_q-wave acute myocardial infarction therapy for acute myocardial infarction-Management of intermediate coronary syndrome therapy for acute myocardial infarction-Microvascular dysfunction in acute myocardial infarction therapy for acute myocardial infarction-Post-hospitalization management of high-risk coronary patients therapy for acute myocardial infarction-process for ensuring optimal cardiovascular intervention and identifying candidates for glycoprotein IIb-IIIa receptor inhibitor therapy therapy for acute myocardial infarction-therapy for acute myocardial infarction-Potential role of abciximab in ischemic cerebrovascular disease therapy for acute myocardial infarction-Trends in acute myocardial infarction management therapy for acute myocardial infarction-Triple therapy for acute myocardial infarction therapy for acute myocardial infarction-use of glycoprotein IIb-IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction therapy-Cardiovascular disease in type-2 diabetes-challenge for treatment and prevention therapy-INSIGHT and NORDIL Trials-Are Calcium Antagonists Equivalent to Established Drug Therapies for Cardiovascular Protection therapy-Intracoronary radiation therapy therapy-New approaches to antiarrhythmic therapy therapy-Therapeutic options for the management ofpatients with cardiac syndrome X therapy-Therapeutic Vasculogenesis Using Human Cord Blood-Derived Endothelial Progenitors therapy-Thrombolytic therapy for acute arterial occlusion therapy-Treatment of supraventricular tachycardias in the new millennium-drugs or radiofrequency catheter ablation therapy-Update on intravenous tissue plasminogen activator for acute stroke-from clinical trials to clinical practice therapy-Urocortin Protects Against Ischemic Injury via a MAPK-depende 危险因素 risk-Renal function-an emerging risk factor for cardiovascular disease risk-Uric acid as a risk factor for cardiovascular disease risk-Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic risk-Association of Serum Bilirubin Concentration with Risk of Coronary Artery Disease risk-Betaine-Homocysteine Methyltransferase-Genomic Sequencing to Hyperhomocysteinemia Disease in Humans risk-Cardiac markers and risk stratification risk-Cardiovascular risk in women risk-Cardiovascular risk in women-1 risk-Established and emerging cardiovascular risk factors risk-Garlic Shows Promise for Improving Some Cardiovascular Risk Factors risk-Genetic Basis of Hyperhomocysteinemia risk-Global risk assessment in the presymptomatic patient risk-Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells risk-Homocysteine-an innocent bystander in vascular disease risk-Homocysteine and atherothrombosis-mechanisms for injury risk-Homocysteine and cardiovascular disease-cause or effect risk-Homocysteine risk-hyperglycemia Controlling postprandial hyperglycemia risk-hyperglycemia risk-hyperglycemia-Effect of the postprandial state on nontraditional risk factors risk-hyperglycemia-hyperglycemia-implications for practice risk-hyperglycemia-Impaired glucose tolerance as a disease risk-hyperglycemia-Pathophysiologic mechanisms of postprandial hyperglycemia risk-hyperglycemia-Postprandial dyslipidemia-an atherogenic disorder risk-Identifying patients at risk for coronary heart disease risk-Identifying patients at risk for coronary heart disease-1 risk-Importance of asymmetrical dimethylarginine in cardiovascular risk risk-Inflammation, Infection, and the Causes of Atherosclerosis risk-insulin resistance syndrome and type 2 diabetes mellitus risk-introduction risk-Is wine good for your heart-A critical review risk-iTriglycerides-risk factor or fellow traveler risk-Low Hepatic Lipase Activity Is a Novel Risk Factor for Coronary Artery Disease risk-Major risk factors and coronary heart disease risk-Moderate alcohol consumption and coronary heart disease risk-Mutated 5,10-methylenetetrahydrofolate reductase, hyperhomocysteinemia and risk for cardiovascular disease risk-Non–High-Density Lipoprotein Cholesterol Level as Potential Risk Predictor and Therapy Target risk-Novel Clinical Markers of Vascular Wall Inflammation risk-Novel Clinical Markers of Vascular Wall Inflammation risk-Obesity as a disease entity risk-Obesity as a risk factor in coronary artery disease risk-Obesity assessment risk-Obesity, the metabolic syndrome, and cardiovascular disease risk-obesity-Cardiologists should target obesity risk-Omega-3 Fatty Acids, Homocysteine, and the Increased Risk of Cardiovascular Mortality in Major Depressive Disorder risk-Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine risk-Proinflammatory effects of angiotensin II and endothelin-targets for progression of cardiovascular disease- risk-Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study risk-Relation of antibiotic use to risk of myocardial infarction in the general population risk-role of psychobiological pathways in socio-economic inequalities in cardiovascular disease risk risk-Roles of homocysteine in cell metabolism risk-Social and psychosocial influences on sudden cardiac death, ventricular arrhythmia and cardiac function risk-Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease risk-The controversy over homocysteine and cardiovascular risk risk-The use of electron-beam computed tomography as a tool for primary prevention risk-United states cholesterol guidelines 2001 risk-Uric acid as a risk factor for cardiovascular disease risk-Vascular Dysfunction in Hyperglycemia risk-What have we learned about the biology of atherosclerosis-The role of inflammation risk-What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes risk-Women and cardiovascular risk, risk-Cardiovascular Risk Intervention by Pharmacists Risks and Benefits of Glycoprotein IIb-IIIa Antagonists in Acute Coronary Syndrome 脂质代谢 lipid-Sphingomyelinase Activity of LDL-A Link between Atherosclerosis, Ceramide, and Apoptosis lipid-Adipogenesis-forces that tip the scales lipid-Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion lipid-Antioxidant Properties of Macrophages Toward Low-Density Lipoprotein lipid-Becoming fat lipid-Catalysis of ACAT may be completed within the plane of the membrane lipid-Caveolin, Cholesterol, and Lipid Droplets lipid-Cholesterol and other membrane active sterols lipid-Cholesterol interactions with phospholipids in membranes lipid-Class B Scavenger Receptors, Caveolae and Cholesterol Homeostasis lipid-Cubilin and Megalin_Partners in Lipoprotein and Vitamin Metabolism lipid-Current Status of Acrolein as a Lipid Peroxidation Product lipid-high-density lipoprotein- lipid-high-density lipoprotein-Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention lipid-high-density lipoprotein-Clinical treatment of dyslipidemia lipid-high-density lipoprotein-Divergent approaches to the treatment of dyslipidemia lipid-high-density lipoprotein-Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol-implications for therapy lipid-high-density lipoprotein-Evaluating niacin in its various forms lipid-high-density lipoprotein-High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease lipid-high-density lipoprotein-ity lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization lipid-high-density lipoprotein-lipid-Differentiating the effects of raising low levels of high-density lipoprotein cholesterol versus lowering normal triglycerides lipid-high-density lipoprotein-Nonpharmacologic management of low levels of high-density lipoprotein cholesterol lipid-high-density lipoprotein-Oxidized LDL and HDL-antagonists in atherothrombosis lipid-high-density lipoprotein-Raising high-density lipoprotein cholesterol with niacin and fibrates lipid-high-density lipoprotein-sity lipoprotein-epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease lipid-high-density lipoprotein-The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides lipid-high-density lipoprotein-The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol lipid-Isolevuglandin-protein Adducts in Oxidized Low Density Lipoprotein and Human Plasma; A Strong Connection with Cardiovascular Disease lipid-Regulation of Lipoprotein Lipase by the Oxysterol Receptors, LXR and LXR lipid-Decorin Links Low-Density Lipoproteins (LDL) to Collagen_A Novel Mechanism for Retention of LDL in the Atherosclerotic Plaque lipid-Detailed Molecular Model of Apolipoprotein A-I on the Surface of High-Density Lipoproteins and Its Functional Implications lipid-DGAT and Triglyceride Synthesis; A New Target for Obesity Treatment lipid-DGAT and Triglyceride Synthesis_A New Target for Obesity Treatment lipid-Diffusion of Nitric Oxide into Low Density Lipoprotein lipid-Dominant Role of the C-Terminal Domain in the Binding of Apolipoprotein(a) to the Protein Core of Proteoglycans and Other Member lipid-Dominant Role of the C-Terminal Domain in the Binding of Apolipoprotein(a) to the Protein Core of Proteoglycans and Other Members of the Vascular Matrix lipid-Eligibility for Lipid-Lowering Drug Therapy in Primary Prevention lipid-Emerging perspectives on lipid management-international approaches and global challenges lipid-Evolution of Methods for Measurement of HDL-Cholesterol lipid-Evolving Functions of Apolipoprotein AIV; From Birds to Mammals lipid-Evolving Functions of Apolipoprotein AIV_From Birds to Mammals lipid-Fatty acid transport proteins-a current view of a growing family lipid-Fatty Acid-binding Protein Multigene Family-Molecular and Genetic Insights into Function lipid-Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory lipid-Influence of Caveolin, Cholesterol, and Lipoproteins on Nitri lipid-Inhibition of Stress-Activated p38 Mitogen-Activated Protein Kinase Induces Low-Density Lipoprotein Receptor Expression lipid-Interaction Between Factor VIII and LDL Receptor-related Protein; Modulation of Coagulation lipid-Intracellular Assembly of VLDL; Two Major Steps in Separate Cell Compartments lipid-Intracellular lipid particles of eukaryotic cells lipid-Isolevuglandin-protein Adducts in Oxidized Low Density Lipoprotein and Human Plasma A Strong Connection with Cardiovascular Disease lipid-Lipoprotein A-I Structure lipid-Lipoprotein Modulation of Subendothelial Heparan Sulfate Proteoglycans (Perlecan) and Atherogenicity lipid-Lipoprotein(a)-from ancestral benefit to modern pathogen lipid-Lipoproteins Containing Apolipoprotein B-100 Are Secreted by the Heart lipid-Lipoxygenase-a versatile biocatalyst for biotransformation of endobiotics and xenobiotics lipid-Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduc lipid-Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance lipid-Modification of Plasma Lipoproteins by Group IIA Phospholipas A2 lipid-Modification of Plasma Lipoproteins by Group IIA Phospholipase A2 lipid-Quantity versus quality of LDL cholesterol in patients with familial hypercholesterolemia_which is more important lipid-Resistin and obesity-associated insulin resistance lipid-role Acyl-CoA thioesterases play in mediating intracellular lipid metabolism lipid-Role of RAP in the Biogenesis of Lipoprotein Receptors Lipids in the Limelight- Lipids in the Limelight-Hedgehog Signaling-A Tale of Two Lipids Lipids in the Limelight-Location, Location, Location-Membrane Targeting Directed by PX Domains Lipids in the Limelight-Lysophospholipids-Receptor Revelations Lipids in the Limelight-Nuclear Receptors and Lipid Physiology Lipids in the Limelight-Prostaglandins and Leukotrienes-Advances in Eicosanoid Biology lipid-Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology lipid-Structure of apolipoprotein B-100 in low density lipoproteins lipid-Structure of lipid bilayers lipid-The Cell Biology and Physiologic Relevance of ApoE Recycling llipid-Intracellular Assembly of VLDL_Two Major Steps in Separate Cell Compartments 血栓与纤溶 tm-Mesenteric Venous Thrombosis tm-Activation of Factor IX by Factor XIa tm-Activation of the Platelet Collagen Receptor Integrin 21; Its Mechanism and Participation in the Physiological Functions of Pla tm-Activation of the Platelet Collagen Receptor Integrin a2b1_Its Mechanism and Participation in the Physiological Functions of Platelets tm-Annexin II; A Mediator of the Plasmin-Plasminogen Activator System tm-Annexin II_A Mediator of the Plasmin-Plasminogen Activator System tm-antithrombotics and anticoagulants-Conclusion tm-antithrombotics and anticoagulants-Fibrin specificity of plasminogen activators, rebound generation of thrombin, and their therapeutic tm-antithrombotics and anticoagulants-Introduction tm-antithrombotics and anticoagulants-New anticoagulants tm-antithrombotics and anticoagulants-New data in treatment of acute coronary syndromes tm-antithrombotics and anticoagulants-Pentasaccharide Org31540-SR90107A clinical trials update tm-antithrombotics and anticoagulantsRecent advances in anticoagulant therapy for acute coronary syndromes tm-antithrombotics and anticoagulants-reversibility of competitive glycoprotein IIb-IIIa receptor-directed platelet inhibition tm-AUTOSOMAL RECESSIVE DEFICIENCIES OF COAGULATION FACTORS tm-blood-Hemostasis and thrombosis-Acute bleeding complications in patients after bone marrow transplantation tm-blood-Hemostasis and thrombosis-Antiphospholipid syndrome-antibodies and antigens tm-blood-Hemostasis and thrombosis-Antiphospholipid syndrome-insights from animal models tm-blood-Hemostasis and thrombosis-Antithrombotic treatments in acute ischemic stroke tm-blood-Hemostasis and thrombosis-Catastrophic antiphospholipid syndrome tm-blood-Hemostasis and thrombosis-D-dimer for the diagnosis of venous thromboembolism tm-blood-Hemostasis and thrombosis-Diagnosis and incidence of inherited von Willebrand disease tm-blood-Hemostasis and thrombosis-Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome tm-blood-Hemostasis and thrombosis-Inherited thrombophilia and fetal loss tm-blood-Hemostasis and thrombosis-Long-term treatment for venous thromboembolism tm-blood-Hemostasis and thrombosis-Mechanisms of platelet aggregation tm-blood-Hemostasis and thrombosis-Molecular mechanisms of drug-induced thrombocytopenia tm-blood-Hemostasis and thrombosis-Plasma kallikrein-kinin system-a revised hypothesis for its physiologic contributions tm-blood-Hemostasis and thrombosis-Platelet glycoprotein polymorphisms as risk factors for thrombosis tm-blood-Hemostasis and thrombosis-Platelet kinetics in immune thrombocytopenic purpura and human immunodeficiency virus thrombocytopenia tm-blood-Hemostasis and thrombosis-Platelets, leukocytes, and coagulation tm-blood-Hemostasis and thrombosis-Role of blood coagulation factor XI in downregulation of fibrinolysis tm-blood-Hemostasis and thrombosis-The role of platelet collagen receptor tm-blood-Hemostasis and thrombosis-Use of recombinant factor VIIa in hereditary bleeding disorders tm-blood-Hemostasis and thrombosis-von Willebrand factor and thrombotic thrombocytopenic purpura tm-blood-Heparin-Binding Exosite of Factor Xa tm-blood-Platelet activation-assessment and quantification tm-blood-Platelet function analyzer (PFA-100)-A tool to quantify congenital or acquired platelet dysfunction tm-blood-Platelets-An Update on Diagnosis and Management of Thrombocytopenic Disorders tm-blood-Role of Activation of the Coagulation Factor VIII in Interaction with vWf tm-blood-Role of Annexin II Tetramer in Plasminogen Activation tm-blood-Role of the Plasminogen System in Fibrin-Homeostasis and Tissue Remodeling tm-blood-Thrombin-Dissociation of Thrombin's Substrate Interactions Using Site-Directed Mutagenesis tm-Catabolism of the Coagulation Factor VIII; Can We Prolong Lifetime of f VIII in Circulation tm-Catabolism of the Coagulation Factor VIII_Can We Prolong Lif tm-Cellular Effects of Initiation of the Extrinsic Pathway of Blood coagulation tm-Current trends in the management of thromboembolic events tm-Dissociation of Thrombin's Substrate Interactions Using Site-Directed Mutagenesis tm-Factor VIIa-Induced Gene Expression; Potential Implications in Pathophysiology tm-Factor VIIa-Induced Gene Expression_Potential Implications in Pathophysiology tm-Hemostasis and thrombosis-Circulating tissue factor and thrombosis tm-Heparin cofactor II inhibits arterial thrombosis after endothelial injury tm-Heparin-Binding Exosite of Factor Xa tm-Interaction Between Factor VIII and LDL Receptor-related Protein tm-Mapping of the Cryptic Integrin-Binding Site in Osteopontin Suggests a New Mechanism by Which Thrombin Can Regulate Inflammation and Tissue Repair tm-New Insight into How Tissue Factor Allosterically Regulates Factor VIIa tm-Plasminogen activator inhibitor-1 is a major stress-regulated gene tm-Platelet polymorphisms and ischemic heart disease tm-Platelets and the Injured Vessel Wall-Rolling into Action tm-Relationship Between Fibrinogen Protein and Fibrinogen Function in Postmyocardial Infarction Patients tm-Role of Activation of the Coagulation Factor VIII in Interaction with vWf, Phospholipid, and Functioning within the Factor Xase Complex tm-Role of Annexin II Tetramer in Plasminogen Activation tm-The Interaction between Anticoagulant Protein S and Complemen Regulatory C4b-binding Protein (C4BP) tm-The Urokinase Receptor Associated Protein (uPARAP-Endo180)_A Novel Internalization Receptor Connected to the Plasminogen Activation System tm-Thrombopoietin-a pan-hematopoietic cytokine tm-Thrombopoietin-a pan-hematopoietic cytokine tm-THROMBOSPONDINS-Multifunctional Regulators of Cell Interactions tm-Tissue Factor in the Heart-Multiple Roles in Hemostasis, Thrombosis, and Inflammation tm-Tissue Factor, the Blood, and the Arterial Wall tm-Tissue Plasminogen Activator for the Treatment of Deep Venous Thrombosis of the Lower Extremity Current Reports-Role of Central Mineralocorticoid Receptors in Cardiovascular Disease Current Reports-Serum Uric Acid As a Cardiovascular Risk Factor for Heart Disease Current Reports-Advances In Device Lead Extraction Current Reports-Alcohol and Cardiovascular Disease Current Reports-An Evidence-based Approach to Diagnosing Renovascular Hypertension Current Reports-Analysis of Dual-Chamber Pacing as a Treatment for Refractory Limiting Symptoms in Patients with Obstructive Hypertrophic Cardiomyopathy Current Reports-Angiotensin-converting Enzyme Inhibitor and Aspirin Interaction in Congestive Heart Failure-Fear or Reality Current Reports-Antiatherogenic Components of Olive Oil Current Reports-Antibiotic Therapy for Treatment of Chlamydia to Prevent Coronary Heart Disease Events Current Reports-Anticoagulant Therapy in Special Circumstances Current Reports-Anticoagulation and Heart Failure Current Reports-Anticoagulation for Acute Coronary Syndromes and Percutaneous Coronary Intervention in Patients with Heparin-induced Thrombocytopenia Current Reports-Antioxidants and Vitamins to Reduce Cardiovascular Disease Current Reports-Antiphospholipid Syndrome, Antiphospholipid Antibodies, and Atherosclerosis Current Reports-Antithrombotic Therapy for Prosthetic Valves-Routine Treatment and Special Considerations Current Reports-Antithrombotic Therapy for Valve Disease-Native and Prosthetic Valves Current Reports-Antithrombotic Therapy in Cardiac Stent Patients Current Reports-Antithrombotic Therapy in Chronic Heart Disease Current Reports-Antithrombotic Therapy in the Cardiac Catheterization Laboratory-Focus on Antiplatelet Agents Current Reports-Antithrombotics and Acute Coronary Syndromes Current Reports-Antithrombotics in the Management of Patients with Acute Coronary Current Reports-Are All b-Blockers the Same for Chronic Heart Failure Current Reports-Are Drugs and Catheter Ablation Effective for Treating Ventricular Arrhythmias Current Reports-Are Implantable Cardioverter-Defibrillators Cost-Effective Current Reports-Are Statins Anti-Inflammatory-Inflammation C-Reactive Protein Current Reports-Assessment and Management of Lipid Abnormalities Current Reports-Assessment of Management of Lipid Abnormalities Current Reports-Asymptomatic Left Ventricular Dysfunction in the Community Current Reports-Athletes Heart and Hypertrophic Cardiomyopathy Current Reports-Benefits of Niacin in Atherosclerosis Current Reports-Beta-Blockers and Spironolactone in Heart Failure Current Reports-Beta-Carotene, Vitamin C, and Vitamin E and Cardiovascular Diseases Current Reports-Beyond Cholesterol Lowering-Deciphering the Benefits of Dietary Intervention on Cardiovascular Diseases Current Reports-Biologic Alternatives to Stents and Grafts Current Reports-Bivalirudin for Percutaneous Coronary Intervention and in Acute Coronary Syndromes Current Reports-Cardiac Markers in the Diagnosis of Acute Coronary Syndromes Current Reports-Cardiomyopathy and Embolization-Risks and Benefits of Anticoagulation in Sinus Rhythm Current Reports-Catheter Ablation of Ventricular Tachycardia Related to Coronary Artery Disease-The Role of Noncontact Mapping Current Reports-Chlamydia Pneumoniae and Atherosclerosis Current Reports-Clinical and Interventional Electrophysiology Current Reports-Clinical Characteristics and Catheter Ablation of Left Ventricular Outflow Tract Tachycardia Current Reports-Clinical Implications of Elevated Lipoprotein(a) Current Reports-Clinical Trial Evidence for the Cardioprotective Effects of Omega-3 Fatty Acids Current Reports-Clinical Trials in Gene Therapy Current Reports-Closed Chest Totally Endoscopic Coronary Artery Bypass Surgery-Fantasy or Reality Current Reports-Colchicine Treatment for Recurrent Pericarditis Current Reports-Combination Lipid-Altering Therapy-An Emerging Treatment Paradigm for the 21st Century Current Reports-Complex Connection Between CD36 and Atherosclerosis, Lipid Metabolism, and Insulin Resistance Syndromes Current Reports-Complications of Oral Antiplatelet Medications Current Reports-Congenital Heart Disease-Current Indications for Antithrombotic Therapy in Pediatric Patients Current Reports-Congenital Heart Disease Current Reports-Constraint-Induced Movement Therapy to Enhance Recovery after Stroke Current Reports-Controversies about Tissue Plasminogen Activator-Extending the Window of Therapy Current Reports-Coronary Anastomotic Devices-Theory and Patented Ideas on Micromechanical Fastening Current Reports-Coronary Heart Disease-Clinical Trials Review Current Reports-Current Issues of Gene Therapy for Cardiovascular Disorders and Antithrombotic Therapy in Chronic Heart Disease Current Reports-Current Management of Patients with Pulmonary Hypertension and Right Ventricular Insufficiency Current Reports-Current Reports-Current Reports-Atherogenesis and the Arginine Hypothesis Current Reports-Current Reports-Plaque Angiogenesis and Atherosclerosis Current Reports-Current Reports-Primary Prevention of Heart Disease in Women Current Reports-Current Reports-The Need for Medicine-Based Evidence As Well as Evidence-Based Medicine Current Reports-Deactivation of the Sympathetic Nervous System in Patients with Chronic Congestive Heart Failure Current Reports-Deep Venous Thrombosis Prophylaxis in Patients with Heart Disease Current Reports-Diabetes and Cardiovascular Disease Current Reports-Diabetes-Statins, Fibrates, or Both- Current Reports-Diagnosis and Treatment of Hyperhomocysteinemia Current Reports-Diastolic Function in Hypertension Current Reports-Diastolic Heart Failure in the Community Current Reports-Diet and Coronary Heart Disease-Clinical Trials Current Reports-Diet and Pharmacologic Therapy of Obesity to Modify Atherosclerosis Current Reports-Dietary Fiber Prevents Carbohydrate-induced Hypertriglyceridemia Current Reports-Differences in Outcome Between Percutaneous Coronary Intervention and Coronary Bypass Grafting Current Reports-Differentiation in the Angiotensin II Receptor 1 Blocker Class on Autonomic Function Current Reports-Dilated Cardiomyopathy Current Reports-Effects of Fish Oils and Fish on Cardiovascular Disease Current Reports-Effects of Neurohormonal Antagonism on Pathologic Left Ventricular Remodeling in Heart Failure Current Reports-Electron Beam Tomography As an Endpoint for Clinical Trials of Antiatherosclerotic Therapy Current Reports-Emerging Indications for Permanent Pacing Current Reports-Endothelial Function As a Therapeutic Target in Coronary Artery Disease Current Reports-Epidemiology and Pathophysiology of Heart Failure Current Reports-Epidemiology and Pathophysiology of Heart Failure-1 Current Reports-Evolving Technology for Coronary and Valvular Surgery Current Reports-Failing Energetics in Failing Hearts Current Reports-Functional Foods and Cardiovascular Disease Current Reports-Gene-Diet Interaction and Plasma Lipid Response to Dietary Intervention Current Reports-Genes and Environment in Type 2 Diabetes and Atherosclerosis in Aboriginal Canadians Current Reports-Genetic Counseling for Congenital Heart Disease-New Approaches for a New Decade Current Reports-Genetics of Atherosclerosis-The Search for Genes Acting At the Level of the Vessel Wall Current Reports-Genetics of Venous and Arterial Thromboembolism Current Reports-Genomics and the Pathophysiology of Heart Failure Current Reports-Global Risk Assessment for Lipid Therapy to Prevent Coronary Heart Disease Current Reports-Good Smooth Muscle Cells in Atherosclerosis Current Reports-Guidelines for the Acute Coronary Syndromes Current Reports-Heart Failure in Blacks-Etiologic and Epidemiologic Differences Current Reports-Herbs and Atherosclerosis Current Reports-High-density Lipoprotein Metabolism-Molecular Targets for New Therapies for Atherosclerosis Current Reports-Hormone Replacement Therapy and Cardiovascular Risk Current Reports-Hormone Replacement Therapy for Prevention of Coronary Heart Disease-Current Evidence Current Reports-Hormone Replacement Therapy in the Prevention and Treatment of Atherosclerosis Current Reports-Hyperglycemia and Cardiovascular Disease Current Reports-Hypertrophic Cardiomyopathy Current Reports-Imaging Techniques to Predict Cardiovascular Risk Current Reports-Implantable Dual-Chamber Cardioverter-Defibrillator-Pacemaker Current Reports-Implications of Recent Heart Failure Trials for Patients with Hypertension Current Reports-Implications of the Atorvastatin Versus Revascularization Treatment (AVERT) Study for the Clinician Current Reports-Insulin Resistance in Human Partial Lipodystrophy Current Reports-Is There a Role for Calcium Channel Blockers in Congestive Heart Failure Current Reports-Ischemic Heart Disease Current Reports-Issues and Challenges with Antithrombotic Therapy in Diabetic Patients with Acute Coronary Syndromes Current Reports-Leadership in Academic Medicine-A Personal Perspective Current Reports-Levosimendan-A Promising Agent for the Treatment of Hospitalized Patients with Decompensated Heart Failure Current Reports-Low Molecular Weight Heparins and Coronary Artery Disease Current Reports-Low-Density Lipoprotein Apheresis in the Treatment of Atherosclerosis and Other Potential Uses Current Reports-Low-level Inotropic Stimulation with Type III Phosphodiesterase Inhibitors in Patients with Advanced Symptomatic Chronic Heart Failure Receiving b-blocking Agents Current Reports-Low-Molecular Weight Heparins in Coronary Artery Disease Current Reports-Management of Atrial Flutter Current Reports-Management of Heart Failure Current Reports-Management of Ventricular Arrhythmias in Adults with Congenital Heart Disease Current Reports-Management of Ventricular Arrhythmias Current Reports-Management of Ventricular Tachycardia in Patients with Clinically Normal Hearts Current Reports-Measurement of Cholesterol in Plasma and Other Body Fluids Current Reports-Medical Treatment of Hypertrophic Cardiomyopathy Current Reports-Methods of Minimizing Inappropriate Implantable Cardioverter-Defibrillator Shocks Current Reports-Minimal Access Aortic Root, Valve, and Complex Ascending Aortic Surgery Current Reports-Minimal Access Reoperative Mitral and Aortic Valve Surgery Current Reports-Mitral Ring Annuloplasty-An Incomplete Correction of Functional Mitral Regurgitation Associated with Left Ventricular Remodeling Current Reports-Myocardial Matrix and the Development and Progression of Ventricular Remodeling Current Reports-Natriuretic Peptides in the Pathophysiology of Congestive Heart Failure Current Reports-New Concepts in Fibrinolysis and Angiogenesis Current Reports-New Concepts in Vascular Nitric Oxide Signaling Current Reports-New Developments in Atherosclerosis Imaging-Electron Beam Tomography Current Reports-New Developments in the Detection of Vulnerable Plaque Current Reports-New Developments in the Prevention of Atherosclerosis in Patients with Low High-density Lipoprotein Cholesterol Current Reports-New Statins and New Doses of Older Statins Current Reports-Novel Inhibitors of Factor X for Use in Cardiovascular Diseases Current Reports-Novel Neurohumoral Factors in Congestive Heart Failure-Adrenomedullin Current Reports-Nutritional Interventions in Cardiovascular Disease-New Challenges and Opportunities Current Reports-Optimal Dietary Strategy to Manage Risk Associated with Various Dyslipidemias Current Reports-Oral Glycoprotein IIb-IIIa Antagonists in Coronary Artery Disease Current Reports-Oral Platelet Glycoprotein IIb-IIIa Inhibition Current Reports-Oxidative Stress in Congestive Heart Failure Current Reports-Pacemakers and Defibrillators for Congestive Heart Failure Current Reports-Pathophysiologic Mechanisms in Pericardial Disease Current Reports-Pathophysiology and Treatment of The Dyslipidemia of Insulin Resistance Current Reports-Pathophysiology of Atherosclerosis-Development, Regression, Restenosis Current Reports-Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction Current Reports-Percutaneous Coronary Intervention Versus Medical Therapy for Coronary Heart Disease Current Reports-Percutaneous Transluminal Septal Myocardial Ablation Current Reports-Peroxisome Proliferator-activated Receptors in Vascular Biology and Atherosclerosis-Emerging Insights for Evolving Paradigms Current Reports-Perspectives on Cardiac Allograft Vasculopathy Current Reports-Platelet Activation in Acute Myocardial Infarction and the Rationale for Combination Therapy Current Reports-Platelet Glycoprotein IIb-IIIa Inhibitors for Acute Coronary Syndromes-Initiate Treatment Early or Wait for the Catheterization Laboratory Current Reports-Platelet Glycoprotein Receptor Site Blockade in Coronary Artery Disease Current Reports-Platelet-Endothelial Interactions in Atherosclerosis Current Reports-Post-Stroke Depression-An Update Current Reports-Post-Stroke Epilepsy Current Reports-potential of the Angiotensin II Receptor 1 Blocker Eprosartan in the Management of Patients with Hypertension or Heart Failure Current Reports-Potential Use of Ca Scanning to Determine the Need for and Intensity of Lipid-lowering Therapy in Asymptomatic Adults Current Reports-Power of Food to Improve Multiple Cardiovascular Risk Factors Current Reports-Prevention of Restenosis with Intravascular beta-Radiotherapy Current Reports-Prevention of Ventricular Arrhythmias in the Congenital Long QT Syndrome Current Reports-Prevenzione Trial on Fish Oil and Vitamin E Supplementation in Myocardial Infarction Survivors Current Reports-Primary Prevention of Coronary Heart Disease Current Reports-Prophylactic Defibrillator Implantation in Patients with Coronary Artery Disease Current Reports-Radiofrequency Catheter Ablation of Atrial Fibrillation Initiated by Spontaneous Ectopic Beats Current Reports-Rational Use of Inotropic Therapy in Heart Failure Current Reports-Recent Developments in Microvascular Angina Current Reports-Recent Role of Imaging in the Diagnosis of Pericardial Disease Current Reports-Regulation of Cell Migration in Atherosclerosis Current Reports-Renin Angiotensin System As a Risk Factor for Coronary Artery Disease Current Reports-Results of the Assessment of Treatment with Lisinopril and Survival Trial Current Reports-Role of Angiotensin-converting Enzyme Inhibitors in the Treatment of Hypertension Current Reports-Role of Chemokines in Atherosclerosis Current Reports-Role of C-Reactive Protein in Cardiovascular Disease Risk Current Reports-Role of Diet in the Prevention and Treatment of Hypertension Current Reports-Role of Endothelin Receptor Antagonists in the Treatment of Chronic Heart Failure Current Reports-Role of Fibric Acids in Atherosclerosis Current Reports-Role of Lipoprotein(a) in the Pathogenesis of Atherosclerotic Cardiovascular Disease and Its Utility as Predictor of Coronary Heart Disease Events Current Reports-Role of Lipoprotein[a] in Atherosclerosis Current Reports-Role of Nitrogen Oxides on Eicosanoid Production During Atherosclerosis-Understanding the Controversies Current Reports-Role of Pharmacologic Treatment to Prevent Sudden Death in the Implantable Cardioverter Defibrillator Era Current Reports-Selective or Nonselective b-Adrenergic Blockade in Patients with Congestive Heart Failure Current Reports-Serum Uric Acid Is Not an Independent Risk Factor for Coronary Heart Disease Current Reports-Should Patients with Asymptomatic Wolff-Parkinson-White Pattern Undergo a Catheter Ablation Current Reports-Soy Proteins and Cardiovascular Disease Current Reports-Statin Therapy and Prevention of Stroke Current Reports-Statin Trials in Progress-Unanswered Questions Current Reports-Statins in Children-What Do We Know and What Do We Need to Do Current Reports-Statins, Hormones, and Women-Benefits and Drawbacks for Atherosclerosis and Osteoporosis Current Reports-Strategies for Catheter Ablation of Scar-related Ventricular Tachycardia Current Reports-Stress Echocardiography in the Diagnosis of Coronary Artery Disease Current Reports-Stroke and Cognition Current Reports-Stroke Prevention in Atrial Fibrillation Current Reports-Surgical Alternatives to Transplantation and Assist Devices in the Treatment of Heart Failure Current Reports-Sympathetic Overactivity in Hypertension-A Risk Factor for Cardiovascular Disease Current Reports-Systolic Hypertension and Cardiovascular Risk Reduction-A Clinical Review Current Reports-Targeting Triglycerides as Prognostic Indicators and Determining Lowest Values for Patient Benefit Current Reports-The Definitions of Acute Coronary Syndrome, Myocardial Infarction, and Unstable Angina Current Reports-The Risk of Congestive Heart Failure-Sobering Lessons from the Framingham Heart Study Current Reports-The Role of Fibric Acid Derivatives in the Secondary Prevention of Coronary Heart Disease Current Reports-The Role of Tumor Necrosis Factor Alpha in the Pathophysiology of Congestive Heart Failure Current Reports-Therapeutic Angiogenesis-Theoretic Problems Using Vascular Endothelial Growth Factor Current Reports-Therapeutic Implications of Escape from Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Heart Failure Current Reports-Therapeutic Modulation of Cellular Cholesterol Efflux Current Reports-Therapeutic Options in Patients with Reduced Ejection Fraction and Nonsustained Ventricular Tachycardia Current Reports-To Define Is Divine Current Reports-Translating Heart Failure Guidelines into Clinical Practice-Clinical Science and the Art of Medicine Current Reports-Treating Ambulatory Ischemia in Coronary Disease by Manipulating the Cell Biology of Atherosclerosis Current Reports-Treatment of Coexisting Diabetes and Hypertension Current Reports-Treatment of Dyslipidemia in Pre-and Postmenopausal Women With and Without Known Atherosclerotic Cardiovascular Disease Current Reports-Treatment Strategies for Microvascular Dysfunction Following Acute Myocardial Infarction Current Reports-Trial Report-Plant Phytoestrogens Reduce the Risk of Coronary Heart Disease Current Reports-Trial Report-Some Implications from the Hypertension Optimal Treatment Study for Recent Recommendations Concerning Guidelines for the Treatment of Hypertension Current Reports-Triglyceride, Small, Dense Low-density Lipoprotein, and the Atherogenic Lipoprotein Phenotype Current Reports-Use of Statins in Acute Coronary Syndromes-The Mechanisms Behind the Outcomes Current Reports-Utility of Intracardiac Echocardiography in Interventional Electrophysiology Current Reports-Vectors for Gene Therapy of Cardiovascular Disease Current Reports-velopment and Assessment of Antiatherosclerotic Therapies Beyond Low-density Lipoprotein Cholesterol and Blood Pressure Current Reports-Ventricular Arrhythmias, Sudden Death, and Prevention in Patients with Hypertrophic Cardiomyopathy Current Reports-Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia-A 16-year Experience Current Reports-Ventricular Unloading and Myocyte Recovery-Insight Gained into the Pathophysiology of Congestive Heart Failure Current Reports-Weighing the Evidence for Infection as a Risk Factor for Coronary Heart Disease Current Reports-What Has Intravascular Ultrasound Taught Us About Plaque Biology Current Reports-What Niche Will Newer Class III Antiarrhythmic Drugs Occupy Current Reports-Will the Real Heart-healthy Diet Please Stand Up! 炎症,免疫与心脏病 imm- Carotid Artery Ligation Induces Platelet-Leukocyte–Dependent Luminal Fibrin, Required for Neointima Development imm- inflammatory response in myocardial infarction imm- role of scavenger receptors in the innate immune system imm- Scavenger Receptor Expression in Human Monocyte-Macrophages and THP-1 Cells - A Potential Mechanism of Increased Atherosclerosis in Hypertension imm- vascular dendritic cells in atherosclerotic arteries imm-Activation of the immune system and coronary artery disease imm-Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE imm-Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats imm-Angiotensin II Induces Leukocyte–Endothelial Cell Interactions In Vivo Via AT1 and AT2 Receptor–Mediated P-Selectin Upregulation imm-Angiotensin, Inflammation, Hypertension, and Cardiovascular Disease imm-Antibodies Against Oxidized LDL and Carotid Artery Intima-Media Thickness imm-Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis imm-Antiinflammatory and Antiarteriosclerotic Actions of HMG-CoA Reductase Inhibitors imm-Anti-Inflammatory Mechanisms in the Vascular Wall imm-Apolipoprotein J-clusterin limits the severity of murine autoimmune myocarditis imm-Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media imm-Association Between Influenza Vaccination and Reduced Risk of Brain Infarction imm-Association Between Pulse Pressure and C-Reactive Protein imm-Association of C-reactive p